Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

+X solely in ALL

Written2017-07Adriana Zamecnikova
Kuwait Cancer Control Center, Department of Hematology, Laboratory of Cancer Genetics, Kuwait; annaadria@yahoo.com

Abstract Review on +X solely in acute lymphoblastic leukemia, with data on clinics.

Keywords X chromosome gain, acute lymphocytic leukemia, gene downregulation, Down syndrome.

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424
ICD-Morpho 9811/3 B lymphoblastic leukaemia/lymphoma, NOS
Atlas_Id 1799
 
  Figure 1. Fluorescence in situ hybridization with centromeric CEP X/Y probe (Abbott Molecular, Vysis, US) showing 2 copies of chromosome X (green signal) on metaphase and interphase cells. Partial karyotype showing an extra copy of chromosome X (inset).

Clinics and Pathology

Disease Acute lymphoblastic leukemia (ALL), virtually all cases display a B-cell phenotype (except 1 T-cell ALL described by Heerema et al., 1998).
Epidemiology 34 patients (17 males and 17 females) aged 1 to 67 years (median 6 years); among them 17 patients were pediatric cases aged 1 to 16 years (median 4 years) (Privitera et al., 1992; Dastugue et al., 1992 ; Pui et al., 1993; Kempski et al., 1997; Heinonen et al., 1999; Silva et al., 2002; Chan et al., 2003; Kristensen et al., 2003; Russell et al., 2009; Lundin et al., 2014; Olsson et al., 2015; Liu et al., 2016). Up to half of these patients were Down syndrome (DS) cases (n=16) aged 1 to 13 years (Kalwinsky et al., 1990; Dastugue et al., 1992 ; Pui et al., 1993; Kempski et al., 1997; Heinonen et al., 1999; Mullighan et al., 2009; 2009; Russell et al., 2009; Lundin et al., 2014;). Adult patients were 20 to 59 years old (median 38 years) (from the known data) (Fuscaldo et al., 1981; Foa et al., 2003; Yamamoto et al., 2004; Chapiro et al., 2010; Eyre et al., 2012; Safavi et al., 2015; Yasuda et al., 2016) (Table 1).
Table 1. Clinical and karyotypic data of ALL patients with +X as a sole anomaly.
 Sex/AgeKaryotype
1 F/5947,XX,+X
2M48,XY,+X,+21c
3F/448,XX,+X,+21c
4M/7 47,XY,+X/47,idem,add(11)(p15)
5M/2 48,XY,+X,+21c
6F/448,XX,+X,+21c
7M46,XY,+X,inv(9)c      at relapse
8F/3 48,XX,+X,+21c
9M 47,XY,+X
10F/3 48,XX,+X,+21c
11F/16 47,XX,+X/47,idem,i(17)(q10)/47,idem,dup(1)(q21q32)
12F/16 47,XX,+X
13M/21 48,XY,del(1)(p22),t(1;19)(q23p13),+mar/47,XY,+X
14F/6 47,XX,+X
15F/53 47,XX,+X      at relapse
16M 48,XY,+X,+21c      PAR1 deletion, P2RY8-CRLF2 by RT-PCR
17M 48,XY,+X,+21c
18F 48,XX,+X,+21c
19F 48,XX,+X,+21c/48,idem,i(17)(q10)
20M 48,XY,+X,+21c
21M 48,XY,+X,+21c
22M 47,XY,+X
23M/4 48,XY,+X,+21c/49,idem,+17
24F/5 48,XX,+X,+21c
25F/3 47,XX,+X
26F/8 47,XX,+X
27F/38 47,XX,+X
28M/22 47,XY,+X      episomal amplification of NUP214-ABL1
29M/1348,XY,+X,+21c
30M/148,XY,+X,+21c
31F/2B47,XX,+X
32M/4147,XY,+X
33F/4 47,XX,+X
34M/20 47,XY,+X

Abbreviations: M, male; F, female
1. Fuscaldo et al., 1981; 2. Kalwinsky et al., 1990; 3. Dastugue et al., 1992; 4. Privitera et al., 1992; 5-6 Pui et al., 1993; 7. Chucrallah et al., 1995; 8. Kempski et al., 1997; 9. Heerema et al., 1998; 10. Heinonen et al., 1999; 11. Silva et al., 2002; 12. Chan et al., 2003; 13. Foa et al., 2003; 14. Kristensen et al., 2003; 15. Yamamoto et al., 2004; 16-22. Mullighan et al., 2009; 23-26. Russell et al., 2009; 27. Chapiro et al., 2010; 28. Eyre et al., 2012; 29-30. Lundin et al., 2014; 31. Olsson et al., 2015; 32. Safavi et al., 2015; 33. Liu et al., 2016; 34. Yasuda et al ., 2016.

Prognosis +X as the sole anomaly may have not affect the prognosis in ALL patients and likely should be considered an indicator of low risk factor (Dastugue et al., 1992).

Cytogenetics

Additional anomalies Out of 34 patients, the extra chromosome X was observed in a sideline in 5: in association with add(11)(p15) in 1 (Privitera et al., 1992), i(17)(q10) / dup(1)(q21q32) in 1 (Silva et al., 2002), del(1)(p22), t(1;19)(q23p13) in 1 (Foa et al., 2003), i(17)(q10) in 1 DS (Mullighan et al., 2009) and +17 in other DS patient (Russell et al., 2009).

Result of the chromosomal anomaly

Fusion Protein
Oncogenesis X-chromosome aneuploidy is a known numerical anomaly in ALL, especially in childhood ALL where it can be detected in nearly all children with a high hyperdiploid karyotype (Heinonen et al., 1999). It is also the most common acquired changes in DS-ALL were it is observed in between 25% and 50% of patients (Pui et al 1993). However, the acquired gain of an X chromosome as a sole abnormality has been observed only in a relatively small number of ALL patients. Notably, up to half of the cases were described in pediatric patients with Down syndrome, indicating that combination of trisomy 21 and +X chromosome seems to be typical of DS-ALL that and may lead to collaboration of genes on chromosomes 21 and X (Malinge et al., 2009). The result of chromosome X gain is an increased gene dosage that alters expression of many genes at the same time some of which could promote oncogenesis. In addition to an increased dosage of genes on chromosome X, recurring cryptic anomalies such as interstitial deletion of Xp22.33/Yp11.32 that juxtaposes the first, noncoding exon of P2RY8 (pseudoautosomal region 1 of chromosomes X and Y) with the coding region of CRLF2 (cytokine receptor-like factor 2) or translocations t(X;14) between these regions and the immunoglobulin heavy chain locus at 14q32.33 may contribute to leukemogenesis in B-cell acute lymphoblastic leukemia (Mullighan 2009; Russell et al., 2009).
  

Bibliography

The spectrum of acute lymphoblastic leukemia with mature B-cell phenotype
Chan NP, Ma ES, Wan TS, Chan LC
Leuk Res 2003 Mar;27(3):231-4
PMID 12537975
 
A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia
Chapiro E, Russell LJ, Struski S, Cavé H, Radford-Weiss I, Valle VD, Lachenaud J, Brousset P, Bernard OA, Harrison CJ, Nguyen-Khac F
Leukemia 2010 Jul;24(7):1362-4
PMID 20485370
 
Adult acute lymphoblastic leukemia at relapse
Chucrallah AE, Stass SA, Huh YO, Albitar M, Kantarjian HM
Cytogenetic, immunophenotypic, and molecular changes Cancer
PMID 8625224
 
Prognostic significance of karyotype in a twelve-year follow-up in childhood acute lymphoblastic leukemia
Dastugue N, Robert A, Payen C, Clément D, Kessous A, Demur C, Rubie H, Plaisancie H, Bourrouillou G, Colombies P
Cancer Genet Cytogenet 1992 Nov;64(1):49-55
PMID 1458450
 
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia
Eyre T, Schwab CJ, Kinstrie R, McGuire AK, Strefford J, Peniket A, Mead A, Littlewood T, Holyoake TL, Copland M, Moorman AV, Harrison CJ, Vyas P
Blood 2012 Nov 22;120(22):4441-3
PMID 23175662
 
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features
Foa R, Vitale A, Mancini M, Cuneo A, Mecucci C, Elia L, Lombardo R, Saglio G, Torelli G, Annino L, Specchia G, Damasio E, Recchia A, Di Raimondo F, Morra E, Volpe E, Tafuri A, Fazi P, Hunger SP, Mandelli F
Br J Haematol 2003 Feb;120(3):484-7
PMID 12580965
 
Myeloproliferative disorders: III
Fuscaldo KE, Brodsky I, Kahn SB, Conroy JF, Marfurt K
CML: Further studies on the role of cytogenetics in diagnosis, prognosis and management Haematologica
PMID 6797881
 
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group
Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG, Lange BJ, Hutchinson RS, Reaman GH, Trigg ME, Arthur DC, Gaynon PS, Uckun FM
J Clin Oncol 1998 Apr;16(4):1270-8
PMID 9552025
 
Acquired X-chromosome aneuploidy in children with acute lymphoblastic leukemia
Heinonen K, Mahlamäki E, Riikonen P, Meltoranta RL, Rahiala J, Perkkiö M
Med Pediatr Oncol 1999 May;32(5):360-5
PMID 10219338
 
Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome
Kalwinsky DK, Raimondi SC, Bunin NJ, Fairclough D, Pui CH, Relling MV, Ribeiro R, Rivera GK
Am J Med Genet Suppl 1990;7:267-71
PMID 2149960
 
Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia
Kempski HM, Chessells JM, Reeves BR
Leukemia 1997 Nov;11(11):1973-7
PMID 9369434
 
High-resolution comparative genomic hybridisation yields a high detection rate of chromosomal aberrations in childhood acute lymphoblastic leukaemia
Kristensen TD, Wesenberg F, Jonsson OG, Carlsen NT, Forestier E, Kirchhoff M, Lundsteen C, Schmiegelow K
Eur J Haematol 2003 Jun;70(6):363-72
PMID 12756018
 
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, Jiang L, Li JF, Wang MJ, Dai YJ, Zhang ZG, Wang Q, Kong J, Chen B, Zhu YM, Weng XQ, Shen ZX, Li JM, Wang J, Yan XJ, Li Y, Liang YM, Liu L, Chen XQ, Zhang WG, Yan JS, Hu JD, Shen SH, Chen J, Gu LJ, Pei D, Li Y, Wu G, Zhou X, Ren RB, Cheng C, Yang JJ, Wang KK, Wang SY, Zhang J, Mi JQ, Pui CH, Tang JY, Chen Z, Chen SJ
EBioMedicine 2016 Jun;8:173-83
PMID 27428428
 
Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries
Lundin C, Forestier E, Klarskov Andersen M, Autio K, Barbany G, Cavelier L, Golovleva I, Heim S, Heinonen K, Hovland R, Johannsson JH, Kjeldsen E, Nordgren A, Palmqvist L, Johansson B; Nordic Society of Pediatric Hematology Oncology (NOPHO); Swedish Cytogenetic Leukemia Study Group (SCLSG); NOPHO Leukemia Cytogenetic Study Group (NLCSG)
J Hematol Oncol 2014 Apr 11;7:32
PMID 24726034
 
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
Malinge S, Izraeli S, Crispino JD
Blood 2009 Mar 19;113(12):2619-28
PMID 19139078
 
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Mullighan CG, Collins-Underwood JR, Phillips LA, Loudin MG, Liu W, Zhang J, Ma J, Coustan-Smith E, Harvey RC, Willman CL, Mikhail FM, Meyer J, Carroll AJ, Williams RT, Cheng J, Heerema NA, Basso G, Pession A, Pui CH, Raimondi SC, Hunger SP, Downing JR, Carroll WL, Rabin KR
Nat Genet 2009 Nov;41(11):1243-6
PMID 19838194
 
Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1
Olsson L, Albitar F, Castor A, Behrendtz M, Biloglav A, Paulsson K, Johansson B
Genes Chromosomes Cancer 2015 May;54(5):315-25
PMID 25727050
 
Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia
Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D, et al
Blood 1992 Apr 1;79(7):1781-8
PMID 1348433
 
Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia
Pui CH, Raimondi SC, Borowitz MJ, Land VJ, Behm FG, Pullen DJ, Hancock ML, Shuster JJ, Steuber CP, Crist WM, et al
J Clin Oncol 1993 Jul;11(7):1361-7
PMID 8315434
 
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, Chapiro E, Gesk S, Griffiths M, Guttery DS, Haferlach C, Harder L, Heidenreich O, Irving J, Kearney L, Nguyen-Khac F, Machado L, Minto L, Majid A, Moorman AV, Morrison H, Rand V, Strefford JC, Schwab C, Tönnies H, Dyer MJ, Siebert R, Harrison CJ
Blood 2009 Sep 24;114(13):2688-98
PMID 19641190
 
Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia
Safavi S, Hansson M, Karlsson K, Biloglav A, Johansson B, Paulsson K
Haematologica 2015 Jan;100(1):55-61
PMID 25261097
 
Cytogenetic analysis of 100 consecutive newly diagnosed cases of acute lymphoblastic leukemia in Rio de Janeiro
Silva ML, Ornellas de Souza MH, Ribeiro RC, Land MG, Boulhosa de Azevedo AM, Vasconcelos F, Otero L, Vasconcelos Z, Bouzas LF, Abdelhay E
Cancer Genet Cytogenet 2002 Sep;137(2):85-90
PMID 12393277
 
An extra X chromosome as a sole abnormality in relapse of an adult acute lymphoblastic leukemia
Yamamoto K, Hato A, Minagawa K, Yakushijin K, Urahama N, Sada A, Okamura A, Ito M, Matsui T
Cancer Genet Cytogenet 2004 Dec;155(2):154-5
PMID 15571803
 
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Taniwaki M, Kurokawa M, Morishita S, Fukayama M, Kiyoi H, Miyazaki Y, Naoe T, Mano H
Nat Genet 2016 May;48(5):569-74
PMID 27019113
 

Citation

This paper should be referenced as such :
Zamecnikova A
+X solely in ALL;
Atlas Genet Cytogenet Oncol Haematol. in press
On line version : http://AtlasGeneticsOncology.org/Anomalies/plusXALLID1799.html


External links

arrayMapMorph ( 9811/3) - arrayMap (UZH-SIB Zurich)  [auto + random 100 samples .. if exist ]   [tabulated segments]
 
 
Disease database+X solely in ALL
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Nov 21 15:08:51 CET 2017


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.